Siemens Unveils Technologies to Accelerate the Industrial AI Revolution at CES 2026
6.1.2026 19:00:00 EET | Business Wire | Press release
At CES 2026, Siemens’ keynote marked a new era of technology for industry and infrastructure, showcasing how customers and partners are harnessing artificial intelligence to transform their businesses. With AI-enabled technologies, deep domain expertise, and trusted partnerships, Siemens is converting this technological leap into measurable benefits for customers, partners, and society.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106633962/en/
Roland Busch, Chief Executive Officer and President of Siemens AG, delivering the keynote address at CES.
“Just as electricity once revolutionized the world, industry is shifting toward elements where AI powers products, factories, buildings, grids and transportation. Industrial AI is no longer a feature; it’s a force that will reshape the next century. Siemens is delivering AI-native capabilities, intelligence embedded end-to-end across design, engineering and operations, to help our customers anticipate issues, accelerate innovation and reduce cost,” said Roland Busch, President and CEO of Siemens AG. “From the most comprehensive digital twin and AI-powered hardware to copilots on the shop floor, we’re scaling intelligence across the physical world, so businesses realize speed, quality and efficiency all at once. This is how we scale a once-in-a-generation technology shift into measurable outcomes.”
Siemens highlighted its long-standing partnership with NVIDIA at CES 2026: The companies are expanding their partnership to build the Industrial AI Operating System – helping customers revolutionize how they design, engineer, and operate physical systems. Siemens and NVIDIA will work together to build AI-accelerated industrial solutions across the full lifecycle of products and production, enabling faster innovation, continuous optimization, and more resilient, sustainable manufacturing. The companies also aim to build the world’s first fully AI-driven, adaptive manufacturing sites globally, starting in 2026 with the Siemens Electronics Factory in Erlangen, Germany, as the first blueprint.
To support development, NVIDIA will provide AI infrastructure, simulation libraries, models, frameworks and blueprints, while Siemens will commit hundreds of industrial AI experts and leading hardware and software. The companies have identified impact areas to make this vision a reality: AI-native EDA, AI-native Simulation, AI-driven adaptive manufacturing and supply chain, and AI-factories.
Siemens also announced that it will be integrating NVIDIA NIM and NVIDIA Nemotron open AI models into its electronic design automation (EDA) software offerings to advance generative and agentic workflows for semiconductor and PCB design. This will both maximize accuracy through domain specialization and significantly lower operational costs by enabling the most efficient model to handle and adapt to every specific need.
“Generative AI and accelerated computing have ignited a new industrial revolution, transforming digital twins from passive simulations into the active intelligence of the physical world,” said Jensen Huang, founder and CEO of NVIDIA. “Our partnership with Siemens fuses the world's leading industrial software with NVIDIA's full-stack AI platform to close the gap between ideas and reality — empowering industries to simulate complex systems in software, then seamlessly automate and operate them in the physical world.”
New Technology Connects Digital Twin with Real-Time, Real-World Data
Siemens’ primary product launch at CES 2026 is the Digital Twin Composer, available on the Siemens Xcelerator Marketplace mid-2026. This new technology brings together Siemens’ comprehensive digital twin, simulations built using NVIDIA Omniverse libraries, and real-time, real-world engineering data.
With the Digital Twin Composer, companies can create a virtual 3D model of any product, process, or plant; put it in a 3D scene of their choosing; then move back and forth through time, precisely visualizing the effects of everything from weather changes to engineering changes. With Siemens’ software as the data backbone, the Digital Twin Composer builds Industrial Metaverse environments at scale, empowering organizations to apply industrial AI, simulation and real-time physical data to make decisions virtually, at speed and scale. Digital Twin Composer is part of Siemens Xcelerator, an industry proven portfolio of software used by companies worldwide to develop digital twins.
PepsiCo and Siemens are digitally transforming select U.S. manufacturing and warehouse facilities by converting them into high-fidelity 3D digital twins that simulate plant operations and the end-to-end supply chain to establish a performance baseline. Within weeks, teams optimized and validated new configurations to boost capacity and throughput, giving PepsiCo a unified, real-time view of operations with flexibility to integrate AI-driven capabilities over time.
Leveraging Siemens’ Digital Twin Composer, NVIDIA Omniverse libraries and computer vision, PepsiCo can now recreate every machine, conveyor, pallet route and operator path with physics-level accuracy, enabling AI agents to simulate, test, and refine system changes - identifying up to 90 percent of potential issues before any physical modifications occur. This approach has already delivered a 20 percent increase in throughput on initial deployment and is driving faster design cycles, nearly 100 percent design validation and 10 to 15 percent reductions in capital expenditure (Capex) by uncovering hidden capacity and validating investments in a virtual environment.
New Industrial Copilots Streamline Manufacturing Operations
Siemens also spotlighted its partnership with Microsoft, in a conversation with Jay Parikh, executive vice president for CoreAI. Together, Siemens and Microsoft are bridging the worlds of IT and operations, with a collaboration centered on using AI to help organizations across industries improve productivity, resilience, and innovation. Among the highlights: co-building the award-winning industrial copilot.
Siemens also announced that it is expanding its set of AI-powered copilots across the industrial value chain. This will embed intelligence that extends from design and simulation to product lifecycle management, manufacturing, and operations.
Siemens will deploy nine new AI-powered copilots for its software offerings, this will include Teamcenter, Polarion, and Opcenter. These copilots, respectively, streamline product data navigation, reducing errors and accelerating time to market; automate compliance, helping to ensure faster regulatory approvals and lower risk; and transform manufacturing processes, driving cost savings and operational efficiency.
These copilots, along with the rest of Siemens’ expanding portfolio of industrial AI solutions, are available to companies of every size on the Siemens Xcelerator Marketplace.
AI-Driven Innovations in Life Sciences, Energy and Manufacturing
In life sciences, Siemens’ acquisition of Dotmatics has enabled the integration of vast research data, fueling drug discovery and development. With Dotmatics’ Luma platform, scientists can unify billions of data points generated across instruments and labs, creating a coherent foundation for AI-driven exploration. Combined with Siemens Simcenter simulation and digital twins, teams can rapidly test molecules, identify promising candidates, and virtually scale production to help life-changing therapies reach patients up to 50% faster and at a lower cost.
In energy, Bob Mumgaard, CEO and co-founder of Commonwealth Fusion Systems, described how the company uses Siemens’ technologies as it leads the path to commercial fusion. Commonwealth Fusion Systems uses design software and a strong data backbone to help it accelerate the development of fusion machines that promise clean, limitless energy for generations to come.
In manufacturing, Siemens announced a collaboration to bring Industrial AI to Meta Ray-Ban AI Glasses. With hands-free, real-time audio guidance, safety insights, and feedback, shop floor workers will feel empowered to solve problems efficiently and confidently.
Technology to Transform the Everyday for Everyone
At the Siemens booth in the North Hall of the Las Vegas Convention Center, Siemens is showcasing how its technology transforms the everyday, for everyone. Featured solutions from Siemens and its customers that bring together design, simulation, automation, AI, and digital twin technology:
- PepsiCo is modernizing its global operations to meet evolving customer demands with greater speed and flexibility. With Siemens, the company is digitalizing manufacturing and warehousing processes, enabling faster innovation, more agile production, and smarter decision-making across its supply chain.
- Commonwealth Fusion Systems is pioneering the future of clean energy with commercial fusion. Faced with the challenges of building an entirely new industry, CFS partnered with Siemens to build a comprehensive data backbone and to accelerate the design and manufacturing of this clean, safe, and nearly limitless energy source.
- Haddy is reshaping manufacturing through AI-powered 3D printing and localized micro factories that deliver sustainable, high-quality products faster and closer to customers. Facing challenges around supply chain disruption, sustainability, and production agility, Haddy partnered with Siemens to streamline design, optimize operations, and scale efficiently.
Siemens is also revolutionizing how industrial automation is experienced with the launch of its eXplore tour mobile experience in North Hall. Housed in an 18-wheel vehicle, the eXplore tour delivers an interactive experience that highlights how Siemens technologies converge to drive continuous operational optimization and unlock new levels of efficiency. After CES, the eXplore tour will continue across the U.S. with stops including Realize LIVE in Detroit and Automate in Chicago.
Siemens is also livestreaming from a broadcast studio in North Hall, presented in collaboration with AWS. The broadcast studio will feature conversations with the industry leaders who are shaping the future of industrial AI – including Peter Koerte, Member of the Managing Board, Chief Technology Officer and Chief Strategy Officer at Siemens.
For the first time, Siemens is hosting its autonomous vehicle experience located at West Hall 4352. The experience will feature Siemens’ new PAVE360 Automotive technology, a system-level digital twin, to accelerate the development of software-defined vehicles. It will demonstrate how this new technology works, with a real vehicle on site, operating autonomously in a completely virtual environment.
Livestream and afterwards a recording of Siemens’ 2026 keynote is available at https://sie.ag/qhKPT
This press release is available at https://sie.ag/2ScPeo
Follow us: www.x.com/siemens_press
Siemens AG (Berlin and Munich) is a leading technology company focused on industry, infrastructure, mobility, and healthcare. The company’s purpose is to create technology to transform the everyday, for everyone. By combining the real and the digital worlds, Siemens empowers customers to accelerate their digital and sustainability transformations, making factories more efficient, cities more livable, and transportation more sustainable. A leader in industrial AI, Siemens leverages its deep domain know-how to apply AI – including generative AI – to real-world applications, making AI accessible and impactful for customers across diverse industries. Siemens also owns a majority stake in the publicly listed company Siemens Healthineers, a leading global medical technology provider pioneering breakthroughs in healthcare. For everyone. Everywhere. Sustainably.
In fiscal 2025, which ended on September 30, 2025, the Siemens Group generated revenue of €78.9 billion and net income of €10.4 billion. As of September 30, 2025, the company employed around 318,000 people worldwide on the basis of continuing operations. Further information is available on the Internet at https://www.siemens.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260106633962/en/
Contacts
Contact for journalists
Siemens AG
Michael Lindner
Tel.: +49 152 26211095; E-Mail: lindner.michael@siemens.com
Siemens USA
Charlie DiPasquale
Phone: +1 240-481-6632; email: charlie.dipasquale@siemens.com
Christine Whitman
Phone: +1 202-316-2347; email: christine.whitman@siemens.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom